Vor Biopharma Inc. Share Price

Vor Biopharma Inc. Share Price

NASDAQ: VOR | Micro Cap
$18.18
-$0.74 (-3.88%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vor Biopharma Inc. Stock Performance

Open
$18.91
Prev. Close
$18.92
Circuit Range
N/A
Day Range
$17.77 - $19.05
Year Range
$6.51 - $25.98
Volume
57,513
Average Traded
$18.11

Vor Biopharma Inc. Share Price Today

As of 18 November 2026, Vor Biopharma Inc.'s share price is $18.18. The stock opened at $18.91, compared to its previous close of $18.92. During today's trading session, Vor Biopharma Inc.'s share price traded between $17.77 and $19.05, with an average price of $18.41. Over the past 52 weeks, the stock has recorded a high of $25.98 and a low of $6.51. In terms of performance, Vor Biopharma Inc.'s share price has risen by 21.31% over the last six months and is up 118.83% on a year-on-year basis.

Vor Biopharma Inc. Share Price Chart

Line chart of the Vor Biopharma Inc. price trend over the selected period. The price fell overall, ranging from 17.77 to 19.05, ending at 18.18.
$17.77$19.05
L
Show Current Price
H

Vor Biopharma Inc. Stock Fundamentals & Key Indicators

Market Cap
$179.52M
PE Ratio (TTM)
0.86
Dividend Yield
0.00%
EPS (TTM)
$22.04
Revenue (TTM)
$0.00
Return On Equity (TTM)
-986.88%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-105.03%

Vor Biopharma Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$1722.86-$219.59-$62.81-$86.73
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-112.75%71.40%-38.08%

Vor Biopharma Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$92.09-$117.86-$116.91-$695.98
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-27.98%0.81%-495.31%

About Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Vor Biopharma Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$19.84
$18.15
-8.15%
Oct 2026
$18.91
$19.76
+3.43%
Sep 2026
$22.62
$19.11
-18.81%
Aug 2026
$20.29
$23.53
+11.17%
Jul 2026
$18.45
$21.16
+14.87%
Jun 2026
$14.47
$18.43
+22.92%
May 2026
$14.32
$14.99
+4.64%
Apr 2026
$18.81
$14.32
-19.66%
Mar 2026
$14.88
$17.83
+15.48%
Feb 2026
$12.46
$15.44
+18.72%
Jan 2026
$13.44
$13.01
-0.65%
Dec 2025
$8.28
$13.09
+57.52%

VOR Share Price FAQs